Sprint Bioscience
Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression
Sprint Bioscience operates in biopharma, biotechnology, pharmaceutical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2009.
The company sits in the biopharma, biotechnology, pharmaceutical segment, where it competes on its core product or service.
European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) is where the company is located.
Directory data places it at the Series_Unknown stage.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $41.7M in funding.
| Sector | Biopharma, Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2009 |
| Employees | c_00011_00050 |
| Stage | series_unknown |
| Total funding | $41,700,000 |
Website: www.sprintbioscience.com
Create a free account